The Valley Desk

Clinical trial reportThe Journal of clinical endocrinology and metabolismPublished

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of clinical endocrinology and metabolism
Published
Subject terms
Humans; Acromegaly; Peptides, Cyclic; Octreotide; Somatostatin; Human Growth Hormone; Insulin-Like Growth Factor I; Receptors, Somatostatin; Ligands; Treatment Outcome; Administration, Oral; Double-Blind Method
PubMed ID
38828555
PubMed Central ID
PMC11651685
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal